View in EDS HTML Full Text PDF Full Text

Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS.

Saved in:
Bibliographic Details
Title: Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS.
Authors: Arnold DL; Montreal Neurological Institute, McGill University, Montreal, QC, Canada/NeuroRx Research, Montreal, QC, Canada., Sprenger T; Department of Neurology, DKD Helios Klinik Wiesbaden, Wiesbaden, Germany/Research Center for Clinical Neuroimmunology and Neuroscience and MS Center, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland., Bar-Or A; Department of Neurology and Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wolinsky JS; McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA., Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland., Kolind S; University of British Columbia, Vancouver, BC, Canada., Bonati U; Hoffmann-La Roche Ltd, Basel, Switzerland., Magon S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., van Beek J; F. Hoffmann-La Roche Ltd, Basel, Switzerland/Biogen, Baar, Switzerland., Koendgen H; F. Hoffmann-La Roche Ltd, Basel, Switzerland/UCB Farchim SA, Bulle, Switzerland., Bortolami O; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Bernasconi C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gaetano L; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Traboulsee A; University of British Columbia, Vancouver, BC, Canada.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2022 Oct; Vol. 28 (12), pp. 1927-1936. Date of Electronic Publication: 2022 Jun 07.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35672926
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Arnold+DL%22">Arnold DL</searchLink>; Montreal Neurological Institute, McGill University, Montreal, QC, Canada/NeuroRx Research, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Sprenger+T%22">Sprenger T</searchLink>; Department of Neurology, DKD Helios Klinik Wiesbaden, Wiesbaden, Germany/Research Center for Clinical Neuroimmunology and Neuroscience and MS Center, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bar-Or+A%22">Bar-Or A</searchLink>; Department of Neurology and Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Wolinsky+JS%22">Wolinsky JS</searchLink>; McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kappos+L%22">Kappos L</searchLink>; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kolind+S%22">Kolind S</searchLink>; University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Bonati+U%22">Bonati U</searchLink>; Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Magon+S%22">Magon S</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22van+Beek+J%22">van Beek J</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland/Biogen, Baar, Switzerland.<br /><searchLink fieldCode="AU" term="%22Koendgen+H%22">Koendgen H</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland/UCB Farchim SA, Bulle, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bortolami+O%22">Bortolami O</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bernasconi+C%22">Bernasconi C</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gaetano+L%22">Gaetano L</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Traboulsee+A%22">Traboulsee A</searchLink>; University of British Columbia, Vancouver, BC, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229509185%22">Multiple sclerosis (Houndmills, Basingstoke, England)</searchLink> [Mult Scler] 2022 Oct; Vol. 28 (12), pp. 1927-1936. <i>Date of Electronic Publication: </i>2022 Jun 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9509185 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-0970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213524585%22">13524585 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35672926
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/13524585221097561
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1927
    Titles:
      – TitleFull: Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Arnold DL
      – PersonEntity:
          Name:
            NameFull: Sprenger T
      – PersonEntity:
          Name:
            NameFull: Bar-Or A
      – PersonEntity:
          Name:
            NameFull: Wolinsky JS
      – PersonEntity:
          Name:
            NameFull: Kappos L
      – PersonEntity:
          Name:
            NameFull: Kolind S
      – PersonEntity:
          Name:
            NameFull: Bonati U
      – PersonEntity:
          Name:
            NameFull: Magon S
      – PersonEntity:
          Name:
            NameFull: van Beek J
      – PersonEntity:
          Name:
            NameFull: Koendgen H
      – PersonEntity:
          Name:
            NameFull: Bortolami O
      – PersonEntity:
          Name:
            NameFull: Bernasconi C
      – PersonEntity:
          Name:
            NameFull: Gaetano L
      – PersonEntity:
          Name:
            NameFull: Traboulsee A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1477-0970
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Multiple sclerosis (Houndmills, Basingstoke, England)
              Type: main
ResultId 1